ENDRA LIFE SCIENCES INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions
ENDRA LIFE SCIENCES INC. (NDRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions of 4.36% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions · last filed 2026-03-31
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, discount for postvesting restrictions for the quarter ending 2024-03-31 was 0.00%.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, discount for postvesting restrictions for the quarter ending 2023-03-31 was 0.00%.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, discount for postvesting restrictions for the quarter ending 2022-03-31 was 0.00%.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, discount for postvesting restrictions for fiscal 2024 was 4.36%.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, discount for postvesting restrictions for fiscal 2023 was 0.00%.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, discount for postvesting restrictions for fiscal 2022 was 0.00%.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangement by share-based payment award, fair value assumptions, discount for postvesting restrictions for fiscal 2021 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions 12 month |
|---|---|---|---|---|
| 2024-12-31 | 4.36% 10-K · filed 2026-03-31 | |||
| 2024-09-30 | 0.00% 10-Q/A · filed 2024-11-21 | |||
| 2024-06-30 | 0.00% 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | 0.00% 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | 0.00% 10-K · filed 2024-03-28 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | 0.00% 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | 0.00% 10-K · filed 2023-03-16 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 0.00% 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 0.00% 10-K · filed 2022-03-30 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | 0.00% 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |